Found: 39
Select item for more details and to access through your institution.
Characterization of an APP/tau rat model of Alzheimer's disease by positron emission tomography and immunofluorescent labeling.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00916-2
- By:
- Publication type:
- Article
Characterization of a Syngeneic Orthotopic Model of Cholangiocarcinoma by [ 18 F]FDG-PET/MRI.
- Published in:
- Cancers, 2024, v. 16, n. 14, p. 2591, doi. 10.3390/cancers16142591
- By:
- Publication type:
- Article
[ 11 C]metoclopramide is a sensitive radiotracer to measure moderate decreases in P-glycoprotein function at the blood-brain barrier.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2024, v. 44, n. 1, p. 142, doi. 10.1177/0271678X231202336
- By:
- Publication type:
- Article
Complete inhibition of ABCB1 and ABCG2 at the blood–brain barrier by co-infusion of erlotinib and tariquidar to improve brain delivery of the model ABCB1/ABCG2 substrate [ 11 C]erlotinib.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2021, v. 41, n. 7, p. 1634, doi. 10.1177/0271678X20965500
- By:
- Publication type:
- Article
Measurement of cerebral ABCC1 transport activity in wild-type and APP/PS1-21 mice with positron emission tomography.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2020, v. 40, n. 5, p. 954, doi. 10.1177/0271678X19854541
- By:
- Publication type:
- Article
Age dependency of cerebral P-glycoprotein function in wild-type and APPPS1 mice measured with PET.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2020, v. 40, n. 1, p. 150, doi. 10.1177/0271678X18806640
- By:
- Publication type:
- Article
Approaching complete inhibition of P-glycoprotein at the human blood-brain barrier: an (R)-[<sup>11</sup>C]verapamil PET study.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2015, v. 35, n. 5, p. 743, doi. 10.1038/jcbfm.2015.19
- By:
- Publication type:
- Article
A novel PET protocol for visualization of breast cancer resistance protein function at the blood-brain barrier.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2012, v. 32, n. 11, p. 2002, doi. 10.1038/jcbfm.2012.112
- By:
- Publication type:
- Article
Dose-response assessment of tariquidar and elacridar and regional quantification of P-glycoprotein inhibition at the rat blood-brain barrier using ( R)-[<sup>11</sup>C]verapamil PET.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2010, v. 37, n. 5, p. 942, doi. 10.1007/s00259-009-1332-5
- By:
- Publication type:
- Article
Limitations of small animal PET imaging with [18F]FDDNP and FDG for quantitative studies in a transgenic mouse model of Alzheimer's disease.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Limitations of Small Animal PET Imaging with [<sup>18</sup>F]FDDNP and FDG for Quantitative Studies in a Transgenic Mouse Model of Alzheimer’s Disease.
- Published in:
- Molecular Imaging & Biology, 2009, v. 11, n. 4, p. 236, doi. 10.1007/s11307-009-0198-z
- By:
- Publication type:
- Article
Synthesis of a [<sup>18</sup>F]fluorobenzothiazole as potential amyloid imaging agent.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2008, v. 51, n. 3, p. 137, doi. 10.1002/jlcr.1476
- By:
- Publication type:
- Article
A comparative small-animal PET evaluation of [C]tariquidar, [C]elacridar and ( R)-[C]verapamil for detection of P-glycoprotein-expressing murine breast cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2012, v. 39, n. 1, p. 149, doi. 10.1007/s00259-011-1941-7
- By:
- Publication type:
- Article
Influence of Cation Transporters (OCTs and MATEs) on the Renal and Hepatobiliary Disposition of [11C]Metoclopramide in Mice.
- Published in:
- Pharmaceutical Research, 2021, v. 38, n. 1, p. 127, doi. 10.1007/s11095-021-03002-2
- By:
- Publication type:
- Article
Effect of P-glycoprotein inhibition at the blood-brain barrier on brain distribution of ( R)-[<sup>11</sup>C]verapamil in elderly vs. young subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2017, v. 83, n. 9, p. 1991, doi. 10.1111/bcp.13301
- By:
- Publication type:
- Article
A Novel Positron Emission Tomography Imaging Protocol Identifies Seizure-Induced Regional Overactivity of P-Glycoprotein at the Blood-Brain Barrier.
- Published in:
- Journal of Neuroscience, 2011, v. 31, n. 24, p. 8803, doi. 10.1523/JNEUROSCI.6616-10.2011
- By:
- Publication type:
- Article
Inhibition of breast cancer resistance protein at the murine blood-brain barrier by Ko143 studied with [<sup>11</sup>C]tariquidar and PET.
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Dose-response assessment of tariquidar for inhibition of P-glycoprotein at the human blood-brain barrier using (R)-[<sup>11</sup>C]verapamil PET.
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Small-animal PET evaluation of [<sup>11</sup>C]MC113 as a PET tracer for P-glycoprotein.
- Published in:
- 2010
- By:
- Publication type:
- Abstract
In vivo dose finding of tariquidar using (R)-[<sup>11</sup>C]verapamil µPET.
- Published in:
- BMC Pharmacology, 2007, v. 7, p. 1, doi. 10.1186/1471-2210-7-S2-A22
- By:
- Publication type:
- Article
P-Glycoprotein inhibition at the blood-brain barrier visualized with (R)-[<sup>11</sup>C]verapamil µPET.
- Published in:
- BMC Pharmacology, 2007, v. 7, p. 1, doi. 10.1186/1471-2210-7-S2-A24
- By:
- Publication type:
- Article
Influence of Multidrug Resistance-Associated Proteins on the Excretion of the ABCC1 Imaging Probe 6-Bromo-7-[<sup>11</sup>C]Methylpurine in Mice.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Assessing the Activity of Multidrug Resistance-Associated Protein 1 at the Lung Epithelial Barrier.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.244038
- By:
- Publication type:
- Article
Assessing the Activity of Multidrug Resistance-Associated Protein 1 at the Lung Epithelial Barrier.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.244038
- By:
- Publication type:
- Article
Assessing the Activity of Multidrug Resistance-Associated Protein 1 at the Lung Epithelial Barrier.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.244038
- By:
- Publication type:
- Article
Assessing the Activity of Multidrug Resistance-Associated Protein 1 at the Lung Epithelial Barrier.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.120.244038
- By:
- Publication type:
- Article
Assessing the Activity of Multidrug Resistance-Associated Protein 1 at the Lung Epithelial Barrier.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.120.244038
- By:
- Publication type:
- Article
Assessing the Activity of Multidrug Resistance-Associated Protein 1 at the Lung Epithelial.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.120.244038
- By:
- Publication type:
- Article
Assessing the Activity of Multidrug Resistance-Associated Protein 1 at the Lung Epithelial Barrier.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.120.244038
- By:
- Publication type:
- Article
Brain Distribution of Dual ABCB1/ABCG2 Substrates Is Unaltered in a Beta-Amyloidosis Mouse Model.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 21, p. 8245, doi. 10.3390/ijms21218245
- By:
- Publication type:
- Article
Comparison of fully-automated radiosyntheses of [<sup>11</sup>C]erlotinib for preclinical and clinical use starting from in target produced [<sup>11</sup>C]CO<sub>2</sub> or [<sup>11</sup>C]CH<sub>4</sub>.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2018, v. 3, n. 1, p. 1, doi. 10.1186/s41181-018-0044-1
- By:
- Publication type:
- Article
Assessing the Functional Redundancy between P-gp and BCRP in Controlling the Brain Distribution and Biliary Excretion of Dual Substrates with PET Imaging in Mice.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 8, p. 1286, doi. 10.3390/pharmaceutics13081286
- By:
- Publication type:
- Article
Functionalization of 68 Ga-Radiolabeled Nanodiamonds with Octreotide Does Not Improve Tumor-Targeting Capabilities.
- Published in:
- Pharmaceuticals (14248247), 2024, v. 17, n. 4, p. 514, doi. 10.3390/ph17040514
- By:
- Publication type:
- Article
Influence of OATPs on Hepatic Disposition of Erlotinib Measured With Positron Emission Tomography.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 1, p. 139, doi. 10.1002/cpt.888
- By:
- Publication type:
- Article
Imaging P-glycoprotein Induction at the Blood-Brain Barrier of a Beta-Amyloidosis Mouse Model with <sup>11</sup>C-Metoclopramide PET.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.237198
- By:
- Publication type:
- Article
Breast Cancer Resistance Protein and P-Glycoprotein Influence In Vivo Disposition of <sup>11</sup>C-Erlotinib.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 12, p. 1930, doi. 10.2967/jnumed.115.161273
- By:
- Publication type:
- Article
Interaction of <sup>11</sup>C-Tariquidar and <sup>11</sup>C-Elacridar with P-Glycoprotein and Breast Cancer Resistance Protein at the Human Blood-Brain Barrier.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 8, p. 1181, doi. 10.2967/jnumed.112.118232
- By:
- Publication type:
- Article
Tariquidar-Induced P-Glycoprotein Inhibition at the Rat Blood--Brain Barrier Studied with (R)-<sup>11</sup>C-Verapamil and PET.
- Published in:
- Journal of Nuclear Medicine, 2008, v. 49, n. 8, p. 1328, doi. 10.2967/jnumed.108.051235
- By:
- Publication type:
- Article
Use of PET Imaging to Assess the Efficacy of Thiethylperazine to Stimulate Cerebral MRP1 Transport Activity in Wild-Type and APP/PS1-21 Mice.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 12, p. 6514, doi. 10.3390/ijms23126514
- By:
- Publication type:
- Article